Shin D, Jo J, Choi M, Kim K, Bae Y, Kim S. Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer. Exp Mol Med. 2023;55:2220-2237 pubmed publisher

Dai H, Chang L, Yang S, Wang S, Su S, Yeh Y. HDAC6 promotes aggressive development of liver cancer by improving egfr mRNA stability. Neoplasia. 2023;35:100845 pubmed publisher

Bora Singhal N, Mohankumar D, Saha B, Colin C, Lee J, Martin M, et al. Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2. Sci Rep. 2020;10:4722 pubmed publisher

Yang F, Wang F, Liu Y, Wang S, Li X, Huang Y, et al. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells. Life Sci. 2018;213:149-157 pubmed publisher

Gravina G, Marampon F, Muzi P, Mancini A, Piccolella M, Negri Cesi P, et al. PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer. Endocr Relat Cancer. 2013;20:321-37 pubmed publisher

Park S, Jun J, Jeong K, Heo H, Sohn J, Lee H, et al. Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer. Oncol Rep. 2011;25:1677-81 pubmed publisher

Husain M, Harrod K. Enhanced acetylation of alpha-tubulin in influenza A virus infected epithelial cells. FEBS Lett. 2011;585:128-32 pubmed publisher

Wang J, Lin A, Lu L. Effect of EGF-induced HDAC6 activation on corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 2010;51:2943-8 pubmed publisher